6/1/2022 Frailty in patients with newly diagnosed diffuse large B-cell lymphoma receiving curative-intent therapy: a population-based study Vijenthira A, Mozessohn L, Nagamuthu C, Liu N, Blunt D, Alibhai S, Prica A, Cheung MC. J Natl Compr Canc Netw. 2022; 20(6):635-42. Epub 2022 Jun 1. DOI: https://doi.org/10.6004/jnccn.2022.7014
2/22/2022 The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes Brailovski E, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein RJ, Mozessohn L. Ann Hematol. 2022; 101(5):1023-30. Epub 2022 Feb 22. DOI: https://doi.org/10.1007/s00277-022-04802-1
1/21/2022 Platelet count and survival after cancer Giannakeas V, Kotsopoulos J, Brooks JD, Cheung MC, Rosella L, Lipscombe L, Akbari MR, Austin PC, Narod SA. Cancers (Basel). 2022; 14(3):549. Epub 2022 Jan 21. DOI: https://doi.org/10.3390/cancers14030549
Toronto Star6/25/2022Article There’s a COVID-prevention drug that can protect vulnerable patients. Doctors say not enough people know about it
The Globe and Mail11/5/2018Article Additional screening for late-stage cancer patients has little benefit, study says